端粒酶调控研究进展

doi:10.16288/j.yczz.15-356

遗传 ›› 2016, Vol. 38 ›› Issue (4): 289-299.doi: 10.16288/j.yczz.15-356

端粒酶调控研究进展

营孙阳, 熊加秀, 麦洪旭, 林佳佳, 姜丽娜, 程龙, 叶棋浓

军事医学科学院生物工程研究所,北京 100850

收稿日期:2015-08-10 修回日期:2015-12-14 出版日期:2016-04-20 发布日期:2016-04-20
通讯作者: 叶棋浓,博士,研究员,研究方向：肿瘤分子生物学。Tel: 010-66931830;E-mail: yeqn66@yahoo.com
程龙,博士,副研究员,研究方向：肿瘤分子生物学。Tel: 010-66931830;E-mail: flonic@163.com
作者简介:营孙阳,硕士研究生,专业方向：遗传学。Tel: 010-66931830;E-mail: 929661078@qq.com
基金资助:
国家自然科学基金项目(编号：81330053)和北京市科技新星计划项目(编号：Z131102000413034)资助[Supported by the National Natural Science Foundation of China (No; 81330053) and Beijing Novo Program (No; Z131102000413034)],

Advances on the regulation of telomerase

Sunyang Ying, Jiaxiu Xiong, Hongxu Mai, Jiajia Lin, Lina Jiang, Long Cheng, Qinong Ye

Beijing Institute of Biotechnology, Beijing 100850, China

Received:2015-08-10 Revised:2015-12-14 Online:2016-04-20 Published:2016-04-20

摘要/Abstract

摘要： 端粒酶主要包括催化组分端粒酶逆转录酶(Telomerase reverse transcriptase, TERT)和端粒酶RNA组分(Telomerase RNA component, TERC),二者与其他端粒酶复合体亚基共同组装成具有延伸端粒末端功能的全酶,在细胞衰老和肿瘤发生过程中发挥关键的作用。端粒酶调控的分子机制复杂,调控过程包括组装前各组分的转录调节、转录后调控、翻译后修饰以及亚细胞定位的调控,还包括组装过程中各组分的运输和装配的调控,以及组装后募集到端粒末端的调控。本文从以上几个方面对端粒酶的调控机制进行了综述,旨在为端粒酶相关领域的研究以及开发以端粒酶为靶点的药物奠定理论基础。

关键词: 端粒酶, 端粒, 调控

Abstract: Telomerase is composed of the catalytic subunit TERT (Telomerase reverse transcriptase),RNA subunit TERC (Telomerase RNA component) and other telomerase associated proteins. These two compartments with other telomerase subunits can assemble a holoenzyme, which maintain the length of telomeres. Telomerase plays important roles in cell senescence and tumor formation. The molecular mechanisms of the regulation of telomerase are very complicated. These processes comprise the regulation of transcription, post-transcription, post-translation and subcellular localization. Trafficking and assemble of TERT and TERC, as well as recruitment to telomeres, are also involved in this process. Here we review the regulation mechanism of telomerase from these aspects, and aim to laid a foundation for telomerase associated research and the drug targeting the telomerase.

Key words: telomerase, telomere, regulation

营孙阳, 熊加秀, 麦洪旭, 林佳佳, 姜丽娜, 程龙, 叶棋浓. 端粒酶调控研究进展[J]. 遗传, 2016, 38(4): 289-299.

Sunyang Ying, Jiaxiu Xiong, Hongxu Mai, Jiajia Lin, Lina Jiang, Long Cheng, Qinong Ye. Advances on the regulation of telomerase[J]. HEREDITAS(Beijing), 2016, 38(4): 289-299.

参考文献

[1] Palm W, de Lange T. How shelterin protects mammalian telomeres. Annu Rev Genet , 2008, 42: 301-334.
[2] O'Sullivan RJ, Karlseder J. Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol , 2010, 11(3): 171-181.
[3] Kabir S, Hockemeyer D, de Lange T. TALEN gene knockouts reveal no requirement for the conserved human shelterin protein Rap1 in telomere protection and length regulation. Cell Rep , 2014, 9(4): 1273-1280.
[4] Aeby E, Lingner J. ALT telomeres get together with nuclear receptors. Cell , 2015, 160(5): 811-813.
[5] Ly H. Genetic and environmental factors influencing human diseases with telomere dysfunction. Clin Exp Med , 2009, 2(2): 114-130.
[6] Fu D, Collins K. Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. Mol Cell , 2007, 28(5): 773-785.
[7] Venteicher AS, Meng ZJ, Mason PJ, Veenstra TD, Artandi SE. Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly. Cell , 2008, 132(6): 945-957.
[8] Zhong F, Savage SA, Shkreli M, Giri N, Jessop L, Myers T, Chen R, Alter BP, Artandi SE. Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Gene Dev , 2011, 25(1): 11-16.
[9] Trochet D, Mergui X, Ivkovic I, Porreca RM, Gerbault-Seureau M, Sidibe A, Richard F, Londono-Vallejo A, Perret M, Aujard F, Riou JF. Telomere regulation during ageing and tumorigenesis of the grey mouse lemur. Biochimie , 2015, 113: 100-110.
[10] Shay JW, Wright WE. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis , 2005, 26(5): 867-874.
[11] Killela PJ, Reitman ZJ, Jiao YC, Bettegowda C, Agrawal N, Diaz LA, Jr., Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He YP, Hruban RH, Jallo GI, Mandahl N, Meeker AK, Mertens F, Netto GJ, Ahmed Rasheed B, Riggins GJ, Rosenquist TA, Schiffman M, Shih IM, Theodorescu D, Torbenson MS, Velculescu VE, Wang TL, Wentzensen N, Wood LD, Zhang M, McLendon RE, Bigner DD, Kinzler KW, Vogelstein B, Papadopoulos N, Yan H. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA , 2013, 110(15): 6021-6026.
[12] Horn S, Figl A, Sivaramakrishna Rachakonda P, Fischer C, Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K, Schadendorf D, Kumar R. TERT promoter mutations in familial and sporadic melanoma. Science , 2013, 339(6122): 959-961.
[13] Kyo S, Takakura M, Fujiwara T, Inoue M. Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci , 2008, 99(8): 1528-1538.
[14] Greenberg RA. Telomeres, crisis and cancer. Curr Mol Med , 2005, 5(2): 213-218.
[15] Borah S, Xi LH, Zaug AJ, Powell NM, Dancik GM, Cohen SB, Costello JC, Theodorescu D, Cech TR. TERT promoter mutations and telomerase reactivation in urothelial cancer. Science , 2015, 347(6225): 1006-1010.
[16] Lacerte A, Korah J, Roy M, Yang XJ, Lemay S, Lebrun JJ. Transforming growth factor-β inhibits telomerase through SMAD3 and E2F transcription factors. Cell Signal , 2008, 20(1): 50-59.
[17] Ballal RD, Saha T, Fan SJ, Haddad BR, Rosen EM. BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage. J Biol Chem , 2009, 284(52): 36083-36098.
[18] Zhu JY, Zhao YJ, Wang SW. Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene. Protein Cell , 2010, 1(1): 22-32.
[19] Wang SW, Hu CG, Zhu JY. Transcriptional silencing of a novel hTERT reporter locus during in vitro differentiation of mouse embryonic stem cells. Mol Biol Cell , 2007, 18(2): 669-677.
[20] Zhang ZX, Wang Y, Tao ZZ, Chen SM, Xiao BK, Zhou T. Subtelomeric demethylation deregulated hTERT expression, telomerase activity, and telomere length in four nasopharyngeal carcinoma c

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

端粒酶调控研究进展

Advances on the regulation of telomerase

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	吕倩雯, 杨永芳. 植物小肽信号生物学功能及其在作物改良中研究进展[J]. 遗传, 2023, 45(9): 813-828.
[2]	于一凡, 欧阳臻, 郭娟, 赵瑜君, 黄璐琦. 植物质体基因工程调控元件研究进展[J]. 遗传, 2023, 45(6): 501-513.
[3]	王舜泽, 江丰, 朱东丽, 杨铁林, 郭燕. Hi-C技术在三维基因组学和疾病致病机理研究中的应用[J]. 遗传, 2023, 45(4): 279-294.
[4]	张茜, 王子豪, 田烨. 跨组织线粒体应激信号交流调控机体衰老研究进展[J]. 遗传, 2023, 45(3): 187-197.
[5]	王承贤, 容益康, 崔敏. 果蝇限制端粒转座子的分子机制[J]. 遗传, 2023, 45(3): 221-228.
[6]	吴丹丹, 朱明昆, 方忠艳, 马伟. 植物B染色体的分子结构组成及遗传机制研究进展[J]. 遗传, 2022, 44(9): 772-782.
[7]	徐思远, 寿佳, 吴强. HS5-1增强子eRNA PEARL对原钙粘蛋白α基因簇的表达调控[J]. 遗传, 2022, 44(8): 695-764.
[8]	谢甜, 王梅, 高瑞钰, 苗艳尼, 张燚铭, 蒋婧. 光控诱导重组系统的开发与应用[J]. 遗传, 2022, 44(8): 655-671.
[9]	郝艳, 雷富民. 适应性演化的分子遗传机制：以高海拔适应为例[J]. 遗传, 2022, 44(8): 635-654.
[10]	罗熹晨, 刘慧, 刘学英, 李欣欣, 廖红, 傅向东. 植物响应环境变化的长距离信号传导[J]. 遗传, 2022, 44(7): 556-566.
[11]	赵岩, 王晨鑫, 杨天明, 李春爽, 张丽宏, 杜冬妮, 王若曦, 王静, 魏民, 巴雪青. DNA氧化损伤8-羟鸟嘌呤与肿瘤的发生发展[J]. 遗传, 2022, 44(6): 466-477.
[12]	张元, 赵语婷, 庄乐南, 贺津. 转录中介体复合物在心血管发育和疾病中的转录调控作用[J]. 遗传, 2022, 44(5): 383-397.
[13]	漆思晗, 王棨临, 张俊有, 刘倩, 李春燕. 增强子调控癌症发生发展的机制研究[J]. 遗传, 2022, 44(4): 275-288.
[14]	曲卉, 柳毅, 陈雅文, 汪晖. 环境因素所致印迹基因改变与子代器官发育[J]. 遗传, 2022, 44(2): 107-116.
[15]	刘聪, 冯佳妮, 李玮玮, 朱伟伟, 薛云新, 王岱, 赵西林. 细胞dNTP库的稳态维持与基因组稳定性[J]. 遗传, 2022, 44(2): 96-106.